http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#Head
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o
http://www.nanopub.org/nschema#hasAssertion
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o
http://www.nanopub.org/nschema#hasProvenance
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#provenance
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o
http://www.nanopub.org/nschema#hasPublicationInfo
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#pubinfo
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_1
http://semanticscience.org/resource/SIO_000139
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_2
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_1
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://amigo.geneontology.org/amigo/term/GO:0042789
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_2
http://purl.obolibrary.org/obo/RO_0002204
http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6349
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_2
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_3
http://semanticscience.org/resource/SIO_000139
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_4
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_3
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://amigo.geneontology.org/amigo/term/GO:0042789
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_4
http://purl.obolibrary.org/obo/RO_0002204
http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6348
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_4
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_5
http://purl.obolibrary.org/obo/BFO_0000066
http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_5
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_3
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_5
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
http://www.selventa.com/vocabulary/decreases
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_5
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_1
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_5
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion
http://www.w3.org/2000/01/rdf-schema#label
tscript(p(HGNC:KLF5)) -| tscript(p(HGNC:KLF4))
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#provenance
http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel
http://purl.org/dc/elements/1.1/description
Approximately 61,000 statements.
http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel
http://purl.org/dc/elements/1.1/rights
Copyright (c) 2011-2012, Selventa. All rights reserved.
http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel
http://purl.org/dc/elements/1.1/title
BEL Framework Large Corpus Document
http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel
http://purl.org/pav/authoredBy
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_8
http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel
http://purl.org/pav/version
1.4
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_6
http://purl.org/dc/elements/1.1/identifier
Cellular and Molecular Biology 26: Transcription Factor Function Abstract 1692
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_6
http://purl.org/dc/elements/1.1/title
Cellular and Molecular Biology 26: Transcription Factor Function Abstract 1692
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_6
http://purl.org/dc/elements/1.1/type
Other
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_7
http://www.w3.org/ns/prov#value
A group of 2-indolyl imidazol [4,5-d] phenanthroline derivatives with potent and selective anti-proliferative activity against several types of human cancer has been developed. A pattern of particular tumor-type selectivity was shown in the in vitro anti-tumor screening of the National Cancer Institute (NCI) Developmental Therapeutics Program. Lead compounds showed potent and selective growth inhibition of colon cancer [N= 6 cell lines; GI50 0.53 +- 0.11 (uM)], leukemia [N=3 cell lines; GI50 0.17 +- 0.09 (uM)], non-small cell lung cancer [NSCLC N = 8 cell lines; GI50 0.95 +- 0.4 (uM)], and prostate cancer [N= 2 cell lines; GI50 0.22 +- 0.05 (uM)]. These compounds also exhibited in vivo activity in the Hollow Fiber Assay, and in xenograft models of human colon carcinoma (HT-29) and NSCLC (H460) in athymic \"nude\" mice. These studies demonstrated significant tumor growth inhibition and in vivo cytocidal effect on implanted cancer cells. Dose-schedule studies defined oral and intraperitoneal therapeutic dosages ranging from 40 mg/Kg to 100 mg/Kg daily x 5 days (tumor volume change ratio T/C = 15-45 %) with no signs of apparent toxicity. Analysis of gene expression by quantitative RT-PCR in tumor xenograft tissue from treated mice showed strong induction of the tumor suppressor gene Kruppel -like factor 4 (KLF4) and decreased expression of the cell cycle associated gene Cyclin D1. Cell cycle analysis by flow cytometry showed that these compounds block the cell cycle progression of HT-29 cells at G1 phase. Additional mechanism of action studies demonstrated that they reduce the concentration of available intracellular zinc, reflected by decreased fluorescent count using the zinc-sensitive dye zinquin, and decreased gene expression of the zinc-storage protein metallothionein 1A. Further studies showed that this effect translated into a series of events that included: (1) reduced gene expression of the metal-responsive transcription factor 1 (MTF-1), as determined by RT-PCR; (2) down-regulation of the KLF4- transcriptional antagonist Kruppel-like factor 5 (KLF5) and induction of KLF4, as determined by RT-PCR and Western blot; and (3) altered expression of several known KLF-4-regulated genes involved in cell cycle progression, including cyclin D1. Taken together, the results indicate intracellular zinc depletion leading to induction of KLF4 as a key process involved in the mechanism of anti-tumor activity of these novel compounds. Additional mechanism of action studies demonstrated that they reduce the concentration of available intracellular zinc, reflected by decreased fluorescent count using the zinc-sensitive dye zinquin, and decreased gene expression of the zinc-storage protein metallothionein 1A. Further studies showed that this effect translated into a series of events that included: (1) reduced gene expression of the metal-responsive transcription factor 1 (MTF-1), as determined by RT-PCR; (2) down-regulation of the KLF4- transcriptional antagonist Kruppel-like factor 5 (KLF5) and induction of KLF4, as determined by RT-PCR and Western blot; and (3) altered expression of several known KLF-4-regulated genes involved in cell cycle progression, including cyclin D1.
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_7
http://www.w3.org/ns/prov#wasQuotedFrom
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_6
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_8
http://www.w3.org/2000/01/rdf-schema#label
Selventa
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion
http://www.w3.org/ns/prov#hadPrimarySource
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_6
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_7
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#pubinfo
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o
http://purl.org/dc/terms/created
2014-07-03T14:29:43.303+02:00
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o
http://purl.org/pav/createdBy
http://orcid.org/0000-0001-6818-334X
http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o
http://purl.org/pav/createdBy
http://orcid.org/0000-0002-1267-0234